Literature DB >> 25612917

The effects of SP110's associated genes on fresh cavitary pulmonary tuberculosis in Han Chinese population.

Shi-Yao Jiang1,2, Lin-Lin Li3, Jun Yue4, Wen-Zhong Chen5, Chao Yang3, Chun-Ling Wan1, Lin He1, Lei Cai6, Shao-Li Deng7.   

Abstract

SP110 is a promising anti-Mycobacterium tuberculosis (MTB) gene. To investigate the effects of SP110 and its associated genes, i.e., MYBBP1A and RELA, on pathological progression of MTB infection, an association study with 424 patients of fresh pulmonary tuberculosis (PTB) and 424 healthy controls was performed. Moreover, classification and regression tree and multifactor dimensionality reduction were employed to explore the effects of gene-gene interactions on cavitary PTB. The results indicated that both the heterozygous genotype GC and homozygous genotype CC in rs3809849 had significant effects on the risk of PTB (OR 1.42, 95 % CI 1.06-1.92, p 0.019; OR 1.55, 95 % CI 1.04-2.33, p = 0.033, respectively), and heterozygous genotype CT in rs9061 also had similar effects (OR 1.43, 95 % CI 1.07-1.90, p = 0.014). The rs3809849 and rs9905742 in MYBBP1A were also significantly associated with cavitary PTB (p = 0.00046 and 0.039, respectively), while rs9061 in SP110 had no such association (p = 0.06931) except its significant association with non-cavitary PTB (p = 0.0093). The interaction of MYBBP1A and RELA had significant effect on cavitary PTB (OR 4.24, 95 % CI 1.44-12.49, p = 0.005). These suggest that MYBBP1A instead of SP110 may be a genetic risk factor for cavitary PTB and play important effects on its whole progress.

Entities:  

Keywords:  CART; MDR; MYBBP1A; SP110; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 25612917     DOI: 10.1007/s10238-015-0339-4

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  14 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

Authors:  Lance W Hahn; Marylyn D Ritchie; Jason H Moore
Journal:  Bioinformatics       Date:  2003-02-12       Impact factor: 6.937

Review 3.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

Authors:  A M Dannenberg
Journal:  Immunol Today       Date:  1991-07

4.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

5.  Identification of genetic associations of SP110/MYBBP1A/RELA with pulmonary tuberculosis in the Chinese Han population.

Authors:  Lei Cai; Shao-Li Deng; Li Liang; Hui Pan; Jia Zhou; Mei-Yan Wang; Jun Yue; Chun-Ling Wan; Guang He; Lin He
Journal:  Hum Genet       Date:  2012-11-06       Impact factor: 4.132

6.  Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa.

Authors:  Kerrie Tosh; Sarah J Campbell; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Lisse; Giorgio Sirugo; Steve Bennett; Peter Aaby; Keith P W J McAdam; Oumou Bah-Sow; Christian Lienhardt; Igor Kramnik; Adrian V S Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-27       Impact factor: 11.205

7.  MYBBP1a is a novel repressor of NF-kappaB.

Authors:  Heather R Owen; Michael Elser; Edwin Cheung; Monika Gersbach; W Lee Kraus; Michael O Hottiger
Journal:  J Mol Biol       Date:  2006-12-15       Impact factor: 5.469

8.  Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.

Authors:  E D Chan; K R Morris; J T Belisle; P Hill; L K Remigio; P J Brennan; D W Riches
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  MYBBP1A: a new Ipr1's binding protein in mice.

Authors:  Lei Cai; Hui Pan; Krzysztof Trzciński; Claudette M Thompson; Qiang Wu; Igor Kramnik
Journal:  Mol Biol Rep       Date:  2010-03-11       Impact factor: 2.316

10.  Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.

Authors:  D B Bloch; A Nakajima; T Gulick; J D Chiche; D Orth; S M de La Monte; K D Bloch
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

View more
  6 in total

Review 1.  Certain Polymorphisms in SP110 Gene Confer Susceptibility to Tuberculosis: A Comprehensive Review and Updated Meta-Analysis.

Authors:  Shuai Zhang; Xue Bin Wang; Ya Di Han; Chen Wang; Ye Zhou; Fang Zheng
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

2.  Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population.

Authors:  Jing Su; Yan Li; Guanglong Su; Jing Wang; Ting Qiu; Rong Ma; Lei Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  TSG-6 in conditioned media from adipose mesenchymal stem cells protects against visual deficits in mild traumatic brain injury model through neurovascular modulation.

Authors:  Kumar Abhiram Jha; Mickey Pentecost; Raji Lenin; Jordy Gentry; Lada Klaic; Nobel Del Mar; Anton Reiner; Chuan He Yang; Lawrence M Pfeffer; Nicolas Sohl; Rajashekhar Gangaraju
Journal:  Stem Cell Res Ther       Date:  2019-11-05       Impact factor: 6.832

4.  Polymorphisms in the ASAP1 and SP110 Genes and Its Association with the Susceptibility to Pulmonary Tuberculosis in a Mongolian Population.

Authors:  Xiaogang Cui; Tianqi Yuan; Pengyuan Ning; Jie Han; Yue Liu; Jiao Feng; Fan Lian; Mingyuan Hao; Li Dong; Jinqi Hao; Li Xing; Changxin Wu
Journal:  J Immunol Res       Date:  2022-09-20       Impact factor: 4.493

5.  SP110 and PMP22 polymorphisms are associated with tuberculosis risk in a Chinese-Tibetan population.

Authors:  Guoxia Ren; Jiangtao You; Xianfeng Gong; Xiucheng Zhang; Lin Zhao; Xianglan Wei; Tianbo Jin; Mingwei Chen
Journal:  Oncotarget       Date:  2016-10-04

6.  The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma.

Authors:  Debolina Ganguly; Meiyun Fan; Chuan He Yang; Blazej Zbytek; David Finkelstein; Martine F Roussel; Lawrence M Pfeffer
Journal:  Oncotarget       Date:  2018-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.